CVS Health Cash on Hand 2012-2025 | CVS
CVS Health cash on hand from 2012 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- CVS Health cash on hand for the quarter ending December 31, 2025 was $10.598B, a 3.59% decline year-over-year.
- CVS Health cash on hand for 2025 was $10.598B, a 3.59% decline from 2024.
- CVS Health cash on hand for 2024 was $10.993B, a 4.03% decline from 2023.
- CVS Health cash on hand for 2023 was $11.455B, a 27.14% decline from 2022.
|
CVS Health Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2025 | $10,598 |
| 2024 | $10,993 |
| 2023 | $11,455 |
| 2022 | $15,723 |
| 2021 | $12,525 |
| 2020 | $10,854 |
| 2019 | $8,056 |
| 2018 | $6,581 |
| 2017 | $1,807 |
| 2016 | $3,458 |
| 2015 | $2,547 |
| 2014 | $2,515 |
| 2013 | $4,177 |
| 2012 | $1,380 |
| 2011 | $1,418 |
|
CVS Health Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-12-31 | $10,598 |
| 2025-09-30 | $11,232 |
| 2025-06-30 | $14,173 |
| 2025-03-31 | $12,654 |
| 2024-12-31 | $10,993 |
| 2024-09-30 | $9,680 |
| 2024-06-30 | $16,262 |
| 2024-03-31 | $13,089 |
| 2023-12-31 | $11,455 |
| 2023-09-30 | $16,188 |
| 2023-06-30 | $16,887 |
| 2023-03-31 | $17,720 |
| 2022-12-31 | $15,723 |
| 2022-09-30 | $19,989 |
| 2022-06-30 | $14,993 |
| 2022-03-31 | $11,342 |
| 2021-12-31 | $12,525 |
| 2021-09-30 | $12,841 |
| 2021-06-30 | $10,125 |
| 2021-03-31 | $8,788 |
| 2020-12-31 | $10,854 |
| 2020-09-30 | $12,087 |
| 2020-06-30 | $17,465 |
| 2020-03-31 | $12,713 |
| 2019-12-31 | $8,056 |
| 2019-09-30 | $7,527 |
| 2019-06-30 | $8,525 |
| 2019-03-31 | $8,322 |
| 2018-12-31 | $6,581 |
| 2018-09-30 | $41,692 |
| 2018-06-30 | $43,911 |
| 2018-03-31 | $42,142 |
| 2017-12-31 | $1,807 |
| 2017-09-30 | $2,560 |
| 2017-06-30 | $2,169 |
| 2017-03-31 | $2,302 |
| 2016-12-31 | $3,458 |
| 2016-09-30 | $2,263 |
| 2016-06-30 | $1,207 |
| 2016-03-31 | $1,864 |
| 2015-12-31 | $2,547 |
| 2015-09-30 | $3,011 |
| 2015-06-30 | $1,404 |
| 2015-03-31 | $1,634 |
| 2014-12-31 | $2,515 |
| 2014-09-30 | $1,210 |
| 2014-06-30 | $1,712 |
| 2014-03-31 | $2,848 |
| 2013-12-31 | $4,177 |
| 2013-09-30 | $1,613 |
| 2013-06-30 | $1,179 |
| 2013-03-31 | $1,556 |
| 2012-12-31 | $1,380 |
| 2012-09-30 | $1,238 |
| 2012-06-30 | $1,828 |
| 2012-03-31 | $2,216 |
| 2011-12-31 | $1,418 |
| 2011-09-30 | $1,712 |
| 2011-06-30 | $2,233 |
| 2011-03-31 | $2,168 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $99.843B | $402.067B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.156B | 27.25 |
| HCA Healthcare (HCA) | United States | $120.821B | 19.12 |
| Elevance Health (ELV) | United States | $76.540B | 11.49 |
| Cencora (COR) | United States | $70.193B | 22.08 |
| Natera (NTRA) | United States | $28.526B | 0.00 |
| Labcorp Holdings (LH) | United States | $23.430B | 17.86 |
| DiDi Global (DIDIY) | China | $21.650B | 20.00 |
| Viatris (VTRS) | United States | $18.163B | 6.77 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.306B | 0.00 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| Solventum (SOLV) | United States | $13.104B | 12.72 |
| Medpace Holdings (MEDP) | United States | $12.148B | 27.98 |
| Revvity (RVTY) | United States | $10.887B | 18.94 |
| CochLear (CHEOY) | Australia | $9.243B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.941B | 15.29 |
| ICON (ICLR) | Ireland | $7.510B | 7.45 |
| Sonic Healthcare (SKHHY) | Australia | $7.449B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.008B | 41.78 |
| HealthEquity (HQY) | United States | $6.312B | 23.60 |
| Avantor (AVTR) | United States | $6.275B | 10.11 |
| Bausch + Lomb (BLCO) | Canada | $6.034B | 39.60 |
| PACS (PACS) | United States | $5.922B | 36.01 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.818B | 0.00 |
| Sotera Health (SHC) | United States | $4.864B | 23.45 |
| Alignment Healthcare (ALHC) | United States | $4.040B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.017B | 18.83 |
| GeneDx Holdings (WGS) | United States | $2.606B | 45.76 |
| Establishment Labs Holdings (ESTA) | United States | $2.168B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.000B | 25.77 |
| Organon (OGN) | United States | $1.921B | 2.15 |
| Pediatrix Medical (MD) | United States | $1.848B | 11.04 |
| Progyny (PGNY) | United States | $1.784B | 35.07 |
| Ardent Health (ARDT) | United States | $1.375B | 4.49 |
| InnovAge Holding (INNV) | United States | $1.134B | 167.20 |
| CareDx (CDNA) | United States | $1.010B | 16.50 |
| Teladoc Health (TDOC) | United States | $0.825B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.740B | 12.11 |
| Nutex Health (NUTX) | United States | $0.705B | 5.39 |
| Omada Health (OMDA) | United States | $0.655B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.641B | 0.00 |
| Embecta (EMBC) | United States | $0.602B | 3.36 |
| Enhabit (EHAB) | United States | $0.565B | 25.36 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.558B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.478B | 8.79 |
| CryoPort (CYRX) | United States | $0.418B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.396B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.367B | 5.90 |
| So-Young (SY) | China | $0.328B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.269B | 0.00 |
| Oncology Institute (TOI) | United States | $0.247B | 0.00 |
| Agilon Health (AGL) | United States | $0.150B | 0.00 |
| LifeMD (LFMD) | United States | $0.134B | 0.00 |
| Beauty Health (SKIN) | United States | $0.133B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.109B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| Biodesix (BDSX) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.078B | 0.00 |
| DocGo (DCGO) | United States | $0.073B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.039B | 0.00 |
| Pomdoctor - (POM) | China | $0.026B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.018B | 5.62 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |